[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
:: ::
برگشت به فهرست مقالات برگشت به فهرست نسخه ها
Comparison of two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in patients with major beta-thalassemia: a randomized open labeled clinical trial
چکیده:   (164 مشاهده)

Background: Beta thalassemia major patients typically require chronic transfusion and iron-chelating agents to reduce serum iron overload. Osveral® is an available Iranian brand name of deferasirox to use by majority of thalassemic patients. The aim of this study was to compare efficacy of Osveral® vs. Exjade® in major beta thalassemia patients. 

Methods: In this randomized clinical trial, all patients received a single daily dose of 30 mg/kg either of Osveral® or Exjade® for 6 months. Primary outcome was the mean of bimonthly changes in serum ferritin concentration and secondary outcomes included mean changes of heart and liver MRI T2* after a year. 

Results: Finally, 80 patients completed the study. The mean serum ferritin level at the end of sixth month significantly decreased in Osveral® and Exjade® groups (p < 0.01). After a year, means cardiac MRI T2* in Osveral® group were changed from 25.9 ± 9.6 ms to 25.4 ± 9.7 ms and in Exjade® group from 24.8 ± 9.2 ms to 26.9 ± 5.9 ms, with no significant difference (p = 0.43). Mean liver MRI T2* for Osveral® and Exjade® groups were 8.6 ± 6.4 ms (baseline 6.3 ± 4.7) and 6.3 ± 4 ms (baseline 4.9±3.5) respectively, and there was no significant difference between two study arms (p = 0.1).

Conclusion: Osveral® decreased significantly the serum ferritin level and improved heart and liver iron overload as efficient as Exjade®. It can be a suitable cost-effective alternative agent in beta thalassemia major patients.

     
نوع مطالعه: Original Article | موضوع مقاله: pharmacology
دریافت: 1399/6/22 | پذیرش: 1400/3/1
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
برگشت به فهرست مقالات برگشت به فهرست نسخه ها
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.04 seconds with 30 queries by YEKTAWEB 4341